The increase in digital health has led more patients to utilize digital tools for medication management, especially those who are battling a chronic condition like epilepsy.  Medisafe’s functionality combined with the resources and education sponsored by UCB provides an elevated level of support for patients. This digital health platform complements ongoing medication therapy to make living with epilepsy easier to manage, and easier to live with. 

“At UCB, we focus on developing resources that deliver a purposeful impact to people living with epilepsy. As part of our ongoing digitalization efforts, the Medisafe app will allow us to continue supporting patients with new, innovative ways of navigating their health,” said Anita Moser, Head of Assets and Optimization for U.S. Neurology, UCB. “The ability to support patients digitally is more important than ever, and we are pleased to deliver personalized and immediate assistance directly to epilepsy patients and their caregivers to help alleviate the gap in care exacerbated by the COVID crisis.”
    
As a company dedicated to deeply understanding people living with epilepsy, and surrounding patients at every step of their journey, we look forward to the impact this partnership will have on helping to build a better future for patients living with epilepsy.